FDA Adverse Event Injury Summary report: N

LEVEEN¿ COACCESS¿

MDR report key: 6835969 · Received August 31, 2017

Report

Report Number
2134265-2017-08651
Event Type
Injury
Date Received
August 31, 2017
Report Date
August 7, 2017
Manufacturer
BOSTON SCIENTIFIC - COSTA RICA (COYOL)
Product Code
GEI
PMA / PMN Number
K012315
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
FR
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

JOURNAL ARTICLE: BALAGEAS ET AL. (2013). EUROPEAN JOURNAL OF RADIOLOGY. TEN-YEAR EXPERIENCE OF PERCUTANEOUS IMAGE-GUIDED RADIOFREQUENCY ABLATION OF MALIGNANT RENAL TUMORS IN HIGH-RISK PATIENTS. EUR RADIOL, 23, 1925-1932. THE COMPLAINT DEVICE WAS NOT RECEIVED FOR ANALYSIS. THE BATCH NUMBER IS UNKNOWN AND THE MANUFACTURING RECORDS FOR THE COMPLAINT. THE ROOT CAUSE IS ANTICIPATED PROCEDURAL COMPLICATIONS AS THIS EVENT IS A KNOWN PHYSIOLOGICAL EFFECT OF THE PROCEDURE AND IS NOTED WITHIN THE DFU. (B)(4).

Description of Event or Problem · 1

REPORTED VIA JOURNAL ARTICLE. IT WAS REPORTED VIA JOURNAL ARTICLE THAT PATIENTS EXPERIENCED COMPLICATIONS POST RADIOFREQUENCY ABLATION (RFA) PROCEDURES. IMMEDIATE COMPLICATIONS OCCURRED WITHIN 3 DAYS PERI-RENAL HEMATOMA, ADRENAL HEMATOMA, RENAL INFARCTION, PNEUMOTHORAX AND LIVER THERMAL INJURY. EARLY COMPLICATIONS OCCURRED WITHIN LESS THEN 7 DAYS ARTERIAL HYPERTENSION, ARTERIAL HYPOTENSION, ACUTE PARANOID REACTION, AEUROLOGICAL PAIN, INFLAMMATORY REACTION OF PANCREATIC CYST, MINIMAL FISTULA WITHOUT URINOMA, CUTE KIDNEY FAILURE WITH TRANSITORY DIALYSIS, HAEMORRHAGING AND TRANSFUSION, CUTANEOUS FISTULA PLUS URINOMA PLUS INFECTION , DUODENAL PERFORATION PLUS ABSCESS. LATE COMPLICATIONS OCCURRED IN GREATER THAN 7 DAYS, LIVER HEMATOMA AT 2 MONTHS, URETERAL STENOSIS PLUS HEMATOMA INFECTION, URETERAL STENOSIS PLUS CUTANEOUS FISTULA.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
614002 LEVEEN¿ COACCESS¿ ELECTROSURGICAL, CUTTING & COAGULATION & ACCESSORIES GEI BOSTON SCIENTIFIC - COSTA RICA (COYOL) M001262230

Patients

Seq Age Sex Outcome Treatment
1 Other